Literature DB >> 18339015

Pulmonary complications of HIV infection.

Mark J Rosen1.   

Abstract

The AIDS epidemic has had a devastating global impact in the last two decades; although prevalence rates are low in Asia and the Pacific, their enormous population is associated with an estimated 1 million people infected with HIV in 2006 alone. Survival from what had been a uniformly fatal illness has improved markedly with combination antiretroviral therapy and restoration of the immune system, but these treatments are expensive and difficult to distribute to the millions who need them around the world. In addition, millions more do not know they are infected with HIV until they develop an opportunistic infection. The lungs are the most frequent sites of these infections, and in different geographic regions, tuberculosis, bacterial pneumonia and Pneumocystis jiroveci are the dominant pathogens. The incidences of lung cancer and HIV-associated pulmonary arterial hypertension are also increasing in patients with HIV infection, and with the use of antiretrovirals, inflammatory disorders associated with immune restoration are being recognized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339015     DOI: 10.1111/j.1440-1843.2007.01167.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis.

Authors:  Brian L Anderson; Ryan J Welch; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

Review 2.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

3.  A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.

Authors:  Sara Gago; Cristina Esteban; Clara Valero; Oscar Zaragoza; Jorge Puig de la Bellacasa; María José Buitrago
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

4.  Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues.

Authors:  Tina Schultheiss; Reiner Schulte; Ulrike Sauermann; Wiebke Ibing; Christiane Stahl-Hennig
Journal:  Retrovirology       Date:  2011-04-11       Impact factor: 4.602

5.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

6.  Molecular Changes of Lung Malignancy in HIV Infection.

Authors:  Jianghua Zheng; Lin Wang; Zenghui Cheng; Zenglin Pei; Zhiyong Zhang; Zehuan Li; Xuan Zhang; Dong Yan; Qianlin Xia; Yanling Feng; Yanzheng Song; Weiping Chen; Xiaoyan Zhang; Jianqing Xu; Jin Wang
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

Review 7.  Multiple roles for chemokines in the pathogenesis of SIV infection.

Authors:  Todd A Reinhart; Shulin Qin; Yongjun Sui
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

Review 8.  Elevated Risk of Venous Thromboembolism in People Living with HIV.

Authors:  Quan Zhang; Fei Peng; Meizhi Li; Qiong Yi; Wei Tang; Shangjie Wu
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.